期刊文献+

整合素连接激酶在糖尿病肾小管上皮细胞转分化中的作用 被引量:3

Effect of integrin-linked kinase on renal tubular epithelial cell transdifferentiation in diabetic rats
下载PDF
导出
摘要 目的:观察整合素连接激酶(ILK)在糖尿病大鼠肾小管上皮细胞中的表达,探讨其与肾小管上皮细胞转分化(EMT)的关系。方法:雄性Wistar大鼠随机分为正常对照组(n=10)、糖尿病模型组(n=10)与糖尿病氯沙坦干预组(n=10)[氯沙坦20mg/(kg.d)];分别于第8周、第16周每组各处死5只大鼠。留取左肾行HE和Masson染色,阅片并计算肾小管间质损伤指数、肾间质胶原面积;免疫组织化学法检测肾小管上皮细胞α-平滑肌肌动蛋白(α-SMA)、波形蛋白(Vimentin)与ILK的表达。结果:与正常对照组比较,糖尿病组大鼠肾小管间质损伤指数、肾间质胶原面积明显增加(P<0.01),肾小管上皮细胞α-SMA,Vimentin和ILK阳性表达面积明显增加(P<0.01),ILK与α-SMA呈正相关(rs=0.621,P<0.05);氯沙坦组大鼠肾小管间质损伤指数、肾间质胶原面积较糖尿病组明显减弱,其肾小管上皮细胞的ILK,α-SMA与Vimentin表达均较糖尿病组明显减弱(P<0.01)。结论:糖尿病大鼠肾小管上皮细胞存在ILK高表达与EMT,二者之间可能有着重要联系;氯沙坦可下调肾小管上皮细胞ILK表达,阻抑EMT。 Objective To determine the effect of integrin-linked kinase (ILK) in renal tubular epithelial cells and its relation to tubular epithelial-myofibroblast transdifferentiation. Methods Wistar rats were randomly divided into 3 groups : Group normal control ( n = 10 ) , Group diabetic without therapy( n = 10)and Group diabetic with Losartan 20 mg/( kg · d) (n = 10 ). Five rats were killed in each group at the 8th and 16th week. The left kidneys were kept for HE and Masson staining to observe the pathological variations in the renal interstitium. ILK, α-SMA and Vimentin in renal tubular epithelial cells were detected by immunohistochemistry analysis. Results Compared with the control group, ILK, α-SMA and Vimentin in renal tubular epithelial cells in Group diabetes gradually increased in immunohistochemistry ( P 〈 0.01 ) ; ILK was consistent with the pathological variation of renal interstitium and was positively correlated to α-SMA ( rs = 0. 621 , P 〈 0.05). In comparison with the Group diabetes, the expression of ILK, α-SMA and Vimentin in renal tubular epithelial cells was apparently declined ( P 〈 0.01 ) in Group diabetes with Losartan. Conclusion Tubular epithelial myofibroblast transdifferentiation and the over-expression of ILK, between which there may be significant connections, are important events in the progression of diabetic nephropathy. Losartan, a blocker of angiotension Ⅱ type Ⅰ receptor, which ILK in diabetic renal tubular epithelial cells, can restrain the transdifferentiation. may down-regulate the expression of procession of epithelial-myofibroblast
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2007年第1期104-108,共5页 Journal of Central South University :Medical Science
基金 湖南省科技攻关项目(05FJ3058 06SK3018) 湖南省中医药科研基金(24201)~~
关键词 糖尿病 整合素连接激酶 肾小管上皮细胞 转分化 氯沙坦 diabetic mellitus integrin-linked kinase renal tubular epithelial cells,transdifferentiation losartan
  • 相关文献

参考文献11

  • 1Jinde K,Nikolic-Paterson D J,Huang X R,et al.Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis[J].Am J Kidney Dis,2001,38(4):761-769.
  • 2Yang J,Dai C,Liu Y,et al.Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis in mice[J].J Am Soc Nephrol,2002,13 (10):2464-2477.
  • 3Li Y J,Yang J W,Dai C S,et al.Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis[J].J Clin Invest,2003,112 (4):503-516.
  • 4赵雅妮,李惊子,王海燕.血管紧张素Ⅱ受体拮抗剂与血管紧张素转换酶抑制剂抗大鼠肾脏纤维化的作用及机制探讨[J].中华老年多器官疾病杂志,2002,1(1):36-40. 被引量:24
  • 5Morcos M,Sayed A A,Bierhaus A,et al.Activation of tubularepithelial cells in diabetic nephropathy[J].Diabetes,2002,51:3532-3544.
  • 6Zeisberg M,Bonner G,Maeshima Y,et al.Renal fibrosis:collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation[J].Am J Pathol,2001,159(4):1313-1321.
  • 7Hanningan G E,Leung Hagecsteijn C,Fitz Gibbon L,et al.Regulation of cell adhesion and anchorage-dependent growth by a new β1-interinlinked protein kinase[J].Nature,1996,379 (6560):91-96.
  • 8Wu C,Dedhar S.Integrin-linked kinase and its interactors:a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes[J].J Cell Biol,2001,155 (4):505-510.
  • 9Hanes D S,Nahar A,Weir M R.The tissue renin-angiotensin-aldosterone system in diabetes mellitus[J].Cruu Hypertens Rep,2004,6 (2):98-105.
  • 10Ritz E.RAS blockade in diabetic nephropathy.Early intervention can dramatically decrease loss of function[J].MMW Fortschr Med,2004,146 (38):12.

二级参考文献8

  • 1[1]Taal MW,Brenner BM. Renoprotective benefits of RAS in hibition: from ACEI to angiotensin Ⅱ antagonists. Kidney Int, 2000,57: 1803-1817.
  • 2[2]Klahr S, Morrissey JJ. Comparative study of ACE inhibi tots and angiotemsin Ⅱ receptor antagonists in interstitial scarring. Kidney Int, 1997, 63: S111-S114.
  • 3[3]Zhou AY, Yu L, Li JZ, et al. Renal protective effects of blocking the intrarenal renin-angiotensin system: angioten sin Ⅱ type 1 receptor antagonist compared with angiotensin converting enzyme inhibitor. Hypertens Res, 2000, 23:391-397.
  • 4[4]Erwig LP, Kluth DC, Rees AJ. Macrophages in renal in flammation. Curr Opin Nephrol Hypertens, 2001, 10:341-347.
  • 5[5]Magil AB, Pichler RH, Johnson RJ. Osteopontin in chronic puromycin aminonucleoside nephrosis. J Am Soc Nephrol, 1997, 8: 1383-1390.
  • 6[6]Cao Z, Cox A, Bonnet F. Increased osteopointin expression following renal ablation is attenuated by angiotensin type 1receptor antagonism. Exp Nephrol, 2002, 10: 19-25.
  • 7[7]Yang N, Wu LL, Nikolic-Paterson DJ, et al. Local mac rophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant, 1998, 13: 1967-1974.
  • 8[8]Badid C, Vincent M, Fouque D, et al. Myofibroblast: a prognostic marker and target cell in progressive renal dis ease. Ren Fail, 2001, 23: 543-549.

共引文献23

同被引文献32

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部